Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis

Approximately, 10–20% of patients with drug eluting stent (DES) in-stent restenosis (ISR) will develop recurrent ISR; yet, the optimal management of recurrent DES-ISR is unknown. We sought to compare the outcomes of recurrent DES-ISR treated with drug eluting balloons (DEB) to those with repeated im...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Coron Artery Dis
Autores principales: Wang, Guozhong, Zhao, Quanming, Chen, Qing, Zhang, Xiaoxia, Tian, Lei, Zhang, Xiaojiang
Formato: Artigo
Lenguaje:Inglês
Publicado: Lippincott Williams & Wilkins 2019
Materias:
PCI
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6791562/
https://ncbi.nlm.nih.gov/pubmed/31464729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MCA.0000000000000784
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares